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Surgery is an effective option for the treatment of drug-resistant epilepsy28 for patients in whom the epilepto-genic zone, defined as “the site of the beginning and 
of primary organization of the epileptic seizures,”21 can be 
safely removed. Despite advancements in the presurgical 
noninvasive workup, a number of patients still undergo in-
tracranial electroencephalography.13,16,17,19,21,22 Stereoelec-
troencephalography (SEEG) is one of the most prominent 
methods for direct recording of brain electrical activity 
and has recently spread beyond the European borders.5,24 
This method is safe, when performed according to rigor-
ous principles.3,20 Many stereotactic devices can be used 
for the implantation of intracerebral electrodes for SEEG. 
The use of a robotic assistant has recently gained popular-
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OBJECTIVE The purpose of this study was to compare the accuracy of Neurolocate frameless registration system and 
frame-based registration for robotic stereoelectroencephalography (SEEG).
METHODS The authors performed a 40-trajectory phantom laboratory study and a 127-trajectory retrospective analysis 
of a surgical series. The laboratory study was aimed at testing the noninferiority of the Neurolocate system. The analysis 
of the surgical series compared Neurolocate-based SEEG implantations with a frame-based historical control group.
RESULTS The mean localization errors (LE) ± standard deviations (SD) for Neurolocate-based and frame-based trajec-
tories were 0.67 ± 0.29 mm and 0.76 ± 0.34 mm, respectively, in the phantom study (p = 0.35). The median entry point LE 
was 0.59 mm (interquartile range [IQR] 0.25–0.88 mm) for Neurolocate-registration–based trajectories and 0.78 mm (IQR 
0.49–1.08 mm) for frame-registration–based trajectories (p = 0.00002) in the clinical study. The median target point LE was 
1.49 mm (IQR 1.06–2.4 mm) for Neurolocate-registration–based trajectories and 1.77 mm (IQR 1.25–2.5 mm) for frame-
registration–based trajectories in the clinical study. All the surgical procedures were successful and uneventful.
CONCLUSIONS The results of the phantom study demonstrate the noninferiority of Neurolocate frameless registra-
tion. The results of the retrospective surgical series analysis suggest that Neurolocate-based procedures can be more 
accurate than the frame-based ones. The safety profile of Neurolocate-based registration should be similar to that of 
frame-based registration. The Neurolocate system is comfortable, noninvasive, easy to use, and potentially faster than 
other registration devices.
https://thejns.org/doi/abs/10.3171/2017.2.FOCUS16539
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ity, with excellent results in terms of application accuracy 
and safety.1,11,12,15,25 Patient registration can be performed 
in frame-based or frameless conditions. Since the fall of 
2008, we have used a robotic assistant in frame-based 
conditions for implanting all SEEG electrodes at Niguarda 
Hospital.4 A new device for frameless registration, com-
patible with our robot, has recently become available. The 
purpose of this paper is to describe the results of 2 studies 
aimed at comparing the accuracy provided by this new 
device with that of frame-based procedures.
Methods
The present article reports on the results of 2 indepen-
dent studies. The first is a laboratory study performed on 
a phantom; the second is a retrospective analysis of a con-
venience surgical series. Both studies were aimed at as-
sessing the stereotactic accuracy of robot-assisted SEEG 
electrode implantation using the Neurolocate patient reg-
istration module (Renishaw Mayfield SA).
The clinical use of the robotic assistant in frame-based 
conditions at our center was detailed in previously pub-
lished papers.4,6,7
The Neurolocate Device
The Neurolocate device is a new, frameless patient 
registration module designed to be used with the Neuro-
mate stereotactic robot (Renishaw Mayfield), a 5-degrees-
of-freedom passive robot. The Neurolocate module has 5 
synthetic ruby balls (Neurolocate fiducial markers [FMs]), 
which are attached to an FM frame by means of 5 carbon-
fiber rods (Fig. 1). The FM frame is, in turn, attached to the 
laser tool holder, which is mounted on the Neuromate arm.
The robotic arm is first moved so that the Neurolocate 
module is very close to the head of the patient, after the 
head holder is attached to the robot, at the beginning of the 
patient registration.
A 3D data set is then obtained with an intraoperative 
CT scanner. Finally, a specific software module is used to 
complete the registration, selecting the center of the Neu-
rolocate FMs in the multiplanar reconstructions provided 
by the Voxim stereotactic planning software (IVS Tech-
nology GmbH) (Fig. 2). The planning software can com-
pute the transformation matrix from the image space to 
the robot space, because the positions of the 5 Neuromate 
FMs are sent by the robot to the control workstation. Thus, 
once the registration has been completed, the robotic arm 
FIG. 1. Photograph of the phantom study setup with the Neurolocate 
frameless registration module in place. The Neurolocate module is 
made of a body (black arrow) with 5 carbon-fiber rods (green arrow) 
supporting synthetic ruby balls (red arrow). The module is attached to 
the robotic arm (white arrow) by means of the laser holder (orange ar-
row).
FIG. 2. Basic steps of Neurolocate registration. A: The Neurolocate 
module is brought very close to the patient’s head, without touching it, 
by moving the robotic arm with a remote control. B: A 3D image data 
set is obtained with the O-arm. C: The centers of the Neurolocate FMs 
are selected in multiplanar reconstructions in a semiautomated proce-
dure by means of the stereotactic software.
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can align the tool holder with the vector of the planned 
trajectories.
Cone-Beam CT
For both the phantom study and the clinical case se-
ries, imaging data sets were acquired with an O-arm 1000 
system (Medtronic). This cone-beam CT scanner is able 
to produce 3D CT–like data sets and 2D projective x-ray 
images. The reconstructed 3D volume is a 200 × 150–mm 
cylinder, described by a series of 12-bit DICOM (Digi-
tal Imaging and Communications in Medicine) files (192 
axial slices, 512 × 512 matrix, 0.415 × 0.415 × 0.833–mm 
anisotropic voxels). We acquired data sets using the pre-
set high-definition and the standard-definition protocols, 
respectively, for the phantom study and the clinical retro-
spective study.
Phantom Study
This was a noninferiority study aimed at testing the 
null hypothesis that the stereotactic accuracy of Neurolo-
cate-based frameless procedures does not differ from that 
of Talairach-frame–based procedures.
The phantom was a humanlike plastic skull without the 
cranial vault. Ten internal FMs (Cranial Marker System, 
Leibinger) were fixed to the skull, covering the 3 cranial 
fossae, bilaterally. Each phantom FM is made of a cra-
nial screw supporting a removable CT-visible target. The 
phantom was fixed to the pillars of a Talairach stereotactic 
frame by means of 4 conical pins. The frame was attached 
to the Neuromate robotic assistant by means of a dedi-
cated support (Fig. 3).
The measuring probe supported a synthetic ruby ball as 
an FM on its tip (probe FM), easily visible on our CT-like 
data sets. The probe was fixed to the tool holder of the ro-
botic arm by means of a dedicated adapter with the length 
set at 100 mm (Fig. 4).
Two experiments (Experiments 1 and 2) were per-
formed. In both experiments registration was performed 
in a frameless condition with the Neurolocate module and 
in a frame-based condition with the dedicated x-ray local-
izers. The position of the phantom was changed between 
the 2 experiments, simulating 2 different surgeries. The 
experiments were otherwise identical.
Neurolocate was brought close to the phantom, at the 
beginning of each experiment. A 3D planning data set was 
obtained, as long as 2 bidimensional (2D) radiographs in 
anteroposterior and laterolateral projection. The Neurolo-
cate registration was then completed with Voxim (Fig. 3). 
Of note, the Tailarach frame served only as a head holder, 
when the Neurolocate module was used. Ten trajectories 
were then planned, targeting the 10 phantom FMs. The 
phantom FM target was removed from its support, and 
the probe was advanced, ideally placing the center of the 
probe FM in the same position of the removed FM tar-
get. This was performed for each trajectory, obtaining 10 
image data sets. The frame-based part of the experiment 
started after the Neurolocate part of the experiment was 
completed. The 2 radiographs previously obtained with 
the planning data set were uploaded into Voxim, and the 
dedicated localizers were selected in both projections, as 
in the clinical setup previously described.4,6 A point-to-
point registration was subsequently performed between 
the 2D images and the 3D data set, selecting the Neuro-
locate FMs and some of the phantom FMs on both the 
image modalities. Thus, the phantom position inside the 
frame space was registered to the robotic workspace. 
Next, 10 image data sets were obtained for visualizing the 
position of the probe FM, targeting the 10 phantom FMs, 
as in the previous section of the experiment.
Overall, 40 trajectories were planned (20 in each ex-
periment), and 40 image data sets were acquired with the 
measurement probe in position. Each data set with the 
positioned probe FM was automatically registered to the 
planning data set, and the quality of the registration was 
visually checked for accuracy. The localization error (LE) 
was subsequently measured in the planning software as 
the Euclidean distance between the center of the phantom 
FM and the center of the probe FM.
Retrospective Clinical Study
We started to use the Neurolocate module systemati-
cally in the fall of 2016 at our center, following a period 
FIG. 3. Left: Photograph of the phantom study setup showing the at-
tachment of the plastic skull to the Talairach frame, the FMs, and the 
localizers. The plastic skull (white arrow) is attached to the pillars of the 
Talairach frame by means of 4 conical pins (yellow arrow). Ten FMs 
with removable targets (black arrow) are fixed to the internal skull. The 
localizers (blue arrow) for bidimensional x-ray registration are attached 
to the base of the frame. Right: Close-up view of the plastic skull and 
removable targets.
FIG. 4. Photographs illustrating the FM targeting in the phantom study.  
Left: The target of FM 2 is indicated by the yellow arrow. Right: The 
measuring probe is driven to the target (red arrow pointing to the tip of 
the probe), once the fiducial marker is removed.
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of preliminary optimization and validation. For the ret-
rospective analysis, we therefore selected a series of 8 
consecutive patients who underwent SEEG implantations 
between September and December 2016.
LE was measured in the planning software as the Eu-
clidean distance between the planned cortical entry point 
and the major axis of the electrode (entry point LE) and 
between the planned target point and the tip of the im-
planted electrode (target point LE). The measurement pro-
cedure was detailed in previous publications.4,6
Data from the 8 selected patients were compared with 
data from a historical control group.4
We intended to check whether the accuracy of a new 
technique, frameless registration with the Neurolocate 
module, was noninferior to frame-based registration with 
a Talairach frame, which was considered as the gold stan-
dard. In fact, we recently reported 237 SEEG procedures 
with 3252 electrodes that caused no major intracranial 
bleeding.2 It was necessary to define which is the higher 
LE still acceptable for SEEG safety, to estimate the confi-
dence interval. The group at Fondation Rothschild, Paris, 
has, over a long period, used the Neuromate stereotactic 
robot in frameless conditions with an ultrasound (US) 
device for patient registration9–11 and reported no major 
bleeding; thus, we obtained useful data from a previous 
phantom study comparing Neuromate accuracy in frame-
based and US-frameless conditions.15 The authors reported 
mean LEs (± SD) in frame-based and US-frameless condi-
tions of 0.86 ± 0.32 mm and 1.95 ± 0.44 mm, respectively. 
Based on these data, we designed a 2-arm study with a 
minimum sample size equal to 12 patients in each arm 
(total sample size 24), reaching a power greater than 99% 
to detect the specified noninferiority, at a significance lev-
el of a = 0.025, accordingly to the suggestions given by 
Chow and coauthors.8
We largely respected the minimum requirements of the 
study design, since we tested 40 trajectories (20 for each 
arm of the study).
Statistical Analysis
Normality of values was tested with the Shapiro-Wilk 
test. Mean values were compared with the Welch 2-sam-
ple t-test, if the data were normally distributed; for data 
that were not normally distributed, median values were 
compared with the Kruskal-Wallis test. Since the phan-
tom study was a noninferiority one, values of p < 0.025 
were considered as evidence of findings not attributable 
to chance. For the retrospective clinical comparison, how-
ever, the significance threshold was set at 0.05. Statisti-
cal analysis was performed with R 3.3, developed by the 
R Foundation for Statistical Computing (https://www.R-
project.org/).
Approvals
The Niguarda Hospital ethics committee approved 
both studies.
Results
Phantom Study
The raw data from the phantom study are reported in 
Table 1. The LE values were normally distributed with 
both Neurolocate and frame-based registration.
The mean LE was 0.67 ± 0.29 mm for Neurolocate-
based trajectories and 0.76 ± 0.34 mm for frame-based 
trajectories (p = 0.35), indicating that the accuracy of 
Neurolocate-based registration is noninferior to that of 
frame-based registration. The LE values for the Neurolo-
cate-based and frame-based trajectories ranged from 0.34 
to 1.37 mm and from 0.16 to 1.54 mm, respectively.
Retrospective Clinical Study
Eight consecutive patients (5 male, 3 female) underwent 
implantation of a total of 127 intracerebral SEEG elec-
trodes with a Neurolocate-registration–based procedure. 
The historical control group was made up of 78 patients 
(49 male, 29 female) who underwent 81 SEEG electrode 
implantation procedures with a frame-registration-based 
procedure, for positioning of a total of 1050 intracerebral 
electrodes.4 The mean age of the patients was 25.5 ± 10.4 
years in the group that underwent Neurolocate-registra-
tion–based procedures and 25 ± 11 years in the group that 
underwent frame-registration–based procedures (p = 0.9).
In 7 of the 8 Neurolocate-registration–based proce-
dures, the patient’s head was fixed with the Talairach 
frame, used only as a head holder. In the remaining proce-
dure, the patient’s head was fixed with a Sugita-like head-
rest system. All of the SEEG procedures were success-
fully completed, and no complications occurred.
The entry point LEs and target point LEs were not nor-
mally distributed. The median entry point LE was 0.59 
mm (IQR 0.25–0.88) for Neurolocate-registration–based 
trajectories and 0.78 mm (IQR 0.49–1.08) for frame-reg-
istration–based trajectories (p = 0.00002). The median 
target point LE was 1.49 mm (IQR 1.06–2.4) for Neuro-
locate-registration–based and 1.77 mm (IQR 1.25–2.5) for 
frame-registration–based trajectories (p = 0.05).
Discussion
To the best of our knowledge, this is the first study re-
porting on the accuracy of Neurolocate-based registration 
with the Neuromate sterotactic robot.
No major bleedings occurred in the previously reported 
237 SEEG procedures (3252 electrodes) performed with 
the frame-based workflow used at our center since fall 
2008.2 Since we demonstrated that Neurolocate registra-
tion is not inferior to the gold standard, it should have a 
safety profile similar to frame-based registration.
Accuracy in Phantom Studies for Robotic Brain Surgery
Our 40-trajectory phantom study demonstrated that the 
stereotactic accuracy obtained with Neurolocate registra-
tion is not inferior to that obtained in frame-based condi-
tions.
Of note, it must be considered that with our method 
the final LE is the sum of 4 components: 1) the geometri-
cal characteristics of the planning image data set, 2) the 
registration error, 3) the intrinsic mechanical error of the 
robotic arm, and 4) the measurement error. The intrinsic 
accuracy of the Neuromate robot, measured at the time of 
the phantom study, was 0.45 mm. Thus, the part of the LE 
Frameless Neurolocate registration accuracy
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caused by the Neurolocate module is only a few tenths of 
a millimeter.
Li et al.15 compared the accuracy of Neuromate in 
frame-based and US-frameless conditions, reporting 
mean (± SD) LEs of 0.86 ± 0.32 mm and 1.95 ± 0.44 mm, 
respectively. Our results in frame conditions are similar, 
while our frameless ones are definitely better. Thus, we 
conclude that the Neurolocate system is the best option 
for frameless registrations with the Neuromate stereotac-
tic robot.
Varma and Eldridge26 reported results from a study 
performed with Neuromate and US-frameless registra-
tion, too. The mean LE was 1.29 mm, taking into account 
that the slice thickness of the CT planning data set was 1.5 
mm, under their best experimental conditions.
Lefranc et al.14 reported a mean accuracy (± SD) of 0.3 
TABLE 1. Results of phantom study
Trajectory Exp No. LE
Target Coordinates (mm) Entry Coordinates (mm)
X Y Z X Y Z
Exp1_Neurolocate_Target01 1 0.41 109.5 64.4 73.2 124.3 64.4 36.8
Exp1_Neurolocate_Target02 1 0.35 141.6 55.0 56.9 138.5 94.3 12.0
Exp1_Neurolocate_Target03 1 0.54 146.7 87.6 71.8 146.7 85.7 1.2
Exp1_Neurolocate_Target04 1 0.51 154.1 108.5 69.5 154.2 110.2 2.1
Exp1_Neurolocate_Target05 1 0.34 145.6 142.7 77.7 145.6 143.8 5.5
Exp1_Neurolocate_Target06 1 0.66 80.6 151.0 80.0 78.9 151.0 2.1
Exp1_Neurolocate_Target07 1 0.36 56.6 111.8 81.3 56.6 110.2 5.9
Exp1_Neurolocate_Target08 1 0.53 71.7 85.4 84.2 71.7 84.7 2.1
Exp1_Neurolocate_Target09 1 0.56 78.7 62.5 56.7 78.7 61.8 3.6
Exp1_Neurolocate_Target10 1 0.69 104.6 49.2 70.8 104.6 45.4 2.9
Exp1_Frame_Target01 1 1.08 109.5 64.4 73.2 124.3 64.4 36.8
Exp1_Frame_Target02 1 1.54 141.6 55.0 56.9 138.5 94.3 12.0
Exp1_Frame_Target03 1 0.60 146.7 87.6 71.8 146.7 85.7 1.2
Exp1_Frame_Target04 1 0.53 154.1 108.5 69.5 154.2 110.2 2.1
Exp1_Frame_Target05 1 0.33 145.6 142.7 77.7 145.6 143.8 5.5
Exp1_Frame_Target06 1 0.73 80.6 151.0 80.0 78.9 151.0 2.1
Exp1_Frame_Target07 1 0.16 56.6 111.8 81.3 56.6 110.2 5.9
Exp1_Frame_Target08 1 1.21 71.8 85.6 84.1 71.7 84.7 2.1
Exp1_Frame_Target09 1 0.73 78.7 62.5 56.7 78.7 61.8 3.6
Exp1_Frame_Target10 1 0.90 104.6 49.2 70.8 104.6 45.4 2.9
Exp2_Neurolocate_Target01 2 0.99 104 66.7 77.7 104 71.7 5.5
Exp2_Neurolocate_Target02 2 0.79 136 52.2 65.7 136 64 4.7
Exp2_Neurolocate_Target03 2 0.64 143.6 85.7 76.9 143.6 87.3 5.5
Exp2_Neurolocate_Target04 2 0.38 153.5 105.2 72.9 153.5 105.3 5.9
Exp2_Neurolocate_Target05 2 0.42 148.4 141.0 76.7 148.4 136.2 5.2
Exp2_Neurolocate_Target06 2 0.75 84.8 156.2 72.1 84.8 151.4 3.6
Exp2_Neurolocate_Target07 2 0.83 56.8 120.3 75.6 56.8 129.3 4.8
Exp2_Neurolocate_Target08 2 1.37 68.4 92.9 82.5 68.4 104.5 7.5
Exp2_Neurolocate_Target09 2 1.17 74.8 66.2 58.7 74.8 71.7 4.8
Exp2_Neurolocate_Target10 2 1.05 97.6 52.1 76.8 97.6 61.8 5.5
Exp2_Frame_Target01 2 0.77 104 66.7 77.7 104 71.7 5.5
Exp2_Frame_Target02 2 1.03 136 52.2 65.7 136 64 4.7
Exp2_Frame_Target03 2 0.69 143.6 85.7 76.9 143.6 87.3 5.5
Exp2_Frame_Target04 2 1.00 153.5 105.2 72.9 153.5 105.3 5.9
Exp2_Frame_Target05 2 0.47 148.4 141.0 76.7 148.4 136.2 5.2
Exp2_Frame_Target06 2 0.46 84.8 156.2 72.1 84.8 151.4 3.6
Exp2_Frame_Target07 2 0.33 56.8 120.3 75.6 56.8 129.3 4.8
Exp2_Frame_Target08 2 1.00 68.4 92.9 82.5 68.4 104.5 7.5
Exp2_Frame_Target09 2 0.72 74.8 66.2 58.7 74.8 71.7 4.8
Exp2_Frame_Target10 2 0.95 97.6 52.1 76.8 97.6 61.8 5.5
Exp = experiment.
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± 0 mm with identical O-arm image data sets, frameless 
laser-based registration, and the ROSA robotic system 
(Medtech) in a 20-trajectory study. Nevertheless, it is dif-
ficult to compare our results with theirs because they did 
not detail the measurement method. We measured the LE 
in the image space, likely overestimating it. However, our 
method is the only one that can be adopted in both phan-
tom and clinical conditions, and therefore it is advanta-
geous to make a comparison between in vitro and in vivo 
conditions.
Minchev et al.18 reported a mean accuracy of 0.6 mm 
(range 0.1–0.9 mm) with a 3D CT data set (slice thick-
ness 0.625 mm), optical tracking registration (Medtronic 
StealthStation S7), and iSYS1 robot (Medizintechnik) in 
a 162-trajectory study. LEs were measured by means of a 
digital caliper. The same group reported a mean accuracy 
(± SD) of 0.8 ± 0.7 mm, based on 5 trajectories, in another 
study. The analysis was carried out in similar conditions, 
adding some hardware for SEEG procedure optimiza-
tion.10
Von Langsdorff et al.27 reported a mean accuracy (± 
SD) of 0.44 ± 0.23 mm, coupling the Fisher frame and 
Neuromate in a 21-trajectory study. Nevertheless, details 
about the planning data sets and the coregistration method 
were not provided.
In conclusion, the above-listed phantom studies suggest 
that US-frameless registration is less accurate than other 
methods. Other registration techniques and devices pro-
vided similar results, but the heterogeneity of study meth-
ods make a rigorous comparison difficult.
Accuracy in Clinical Studies for SEEG
SEEG-derived accuracy estimation is intrinsically dif-
ferent from deep brain stimulation and biopsy procedures, 
under clinical conditions. In fact, SEEG electrodes are 
semirigid and implanted without any guide tubes, so intra-
cranial deviations can occur. Therefore, the entry point LE 
is the best measure to evaluate the accuracy of the stereo-
tactic system in SEEG implantations. The cortical entry 
point is also the most important region for safety profiles.4
Gonzalez-Martinez et al.12 reported a median entry 
point LE of 1.2 mm (IQR 0.78–1.83 mm) from 500 elec-
trodes implanted with the ROSA robot in frameless condi-
tions. 
Dorfer et al.10 reported a mean entry point LE of 1.3 
mm (range 0.1–3.4 mm) from 93 electrodes implanted with 
optical tracking registration and an iSYS1 robot. For the 
subset of the most recent 31 electrode implantations with 
optimized hardware, they reported a mean entry point LE 
(± SD) of 1.18 ± 0.5 mm.
Roessler et al.,23 reported a mean entry point LE (± SD) 
of 1.4 ± 1.2 mm from 58 electrodes implanted with the use 
of an intraoperative MR scanner (Magnetom Sonata; Sie-
mens Medical Solutions) and an optical-tracking–based 
navigation system (Brainlab AG).
In summary, all of the previously reported entry point 
LEs are larger than 1 mm in real clinical conditions, while 
our results with Neuromate have been submillimetric with 
both frame-based and Neurolocate registration methods. 
This suggests that use of the Neurolocate system could 
further reduce the rate of intracranial bleedings, although 
our clinical results are based on only 127 trajectories from 
8 patients.2
Our experience with the Neurolocate system is limited. 
Nevertheless, it is a promising tool that provides an accu-
rate and easy registration with a compatible intraoperative 
CT scanner. We do not need to take the patient to an exter-
nal CT room, thanks to the availability of the intraopera-
tive imaging system.
In the future, we will collect further data to assess 
whether Neurolocate registration can effectively reduce 
SEEG surgical time.
Conclusions
The Neurolocate patient registration module is a brand 
new, frameless, noninvasive registration tool compatible 
with Neuromate robotic assistant. Its use can increase the 
ease of modern robotic SEEG procedures, while still hav-
ing an accuracy and safety profile similar to that of frame-
based registration.
Acknowledgments
We thank Renishaw Mayfield for providing us with the mea-
surement probe.
References
 1. Abhinav K, Prakash S, Sandeman DR: Use of robot-guided 
stereotactic placement of intracerebral electrodes for inves-
tigation of focal epilepsy: initial experience in the UK. Br J 
Neurosurg 27:704–705, 2013
 2. Cardinale F: Stereoelectroencephalography: application ac-
curacy, efficacy, and safety. World Neurosurg 94:570–571, 
2016
 3. Cardinale F, Casaceli G, Raneri F, Miller J, Lo Russo G: 
Implantation of stereoelectroencephalography electrodes: a 
systematic review. J Clin Neurophysiol 33:490–502, 2016
 4. Cardinale F, Cossu M, Castana L, Casaceli G, Schiariti MP, 
Miserocchi A, et al: Stereoelectroencephalography: surgical 
methodology, safety, and stereotactic application accuracy in 
500 procedures. Neurosurgery 72:353–366, 2013
 5. Cardinale F, González-Martínez J, Lo Russo G: SEEG, Hap-
py Anniversary! World Neurosurg 85:1–2, 2016 (Letter)
 6. Cardinale F, Miserocchi A, Moscato A, Cossu M, Castana L, 
Schiariti MP, et al: Talairach methodology in the multimodal 
imaging and robotics era, in Scarabin JM (ed): Stereotaxy 
and Epilepsy Surgery. Montrouge, France: John Libbey Eu-
rotext, 2012, pp 245–272
 7. Cardinale F, Pero G, Quilici L, Piano M, Colombo P, Mosca-
to A, et al: Cerebral angiography for multimodal surgical 
planning in epilepsy surgery: description of a new three-
dimensional technique and literature review. World Neuro-
surg 84:358–367, 2015
 8. Chow SC, Wang H, Shao J (eds): Sample Size Calculations 
in Clinical Research, ed 2. New York: Chapman and Hall/
CRC, 2008
 9. Delalande O, Dorfmüller G, Ferrand-Sorbets S: Epilepsy 
surgery in children, in Scarabin JM (ed): Stereotaxy and 
Epilepsy Surgery. Montrouge, France: John Libbey Euro-
text, 2012, pp 329–339
10. Dorfer C, Minchev G, Czech T, Stefanits H, Feucht M, Pa-
taraia E, et al: A novel miniature robotic device for frame-
less implantation of depth electrodes in refractory epilepsy. 
J Neurosurg [epub ahead of print August 5, 2016. DOI: 
10.3171/2016.5.JNS16388]
11. Dorfmüller G, Ferrand-Sorbets S, Fohlen M, Bulteau C, 
Frameless Neurolocate registration accuracy
Neurosurg Focus Volume 42 • May 2017 7
Archambaud F, Delalande O, et al: Outcome of surgery in 
children with focal cortical dysplasia younger than 5 years 
explored by stereo-electroencephalography. Childs Nerv 
Syst 30:1875–1883, 2014
12. González-Martínez J, Bulacio J, Thompson S, Gale J, 
Smithason S, Najm I, et al: Technique, results, and complica-
tions related to robot-assisted stereoelectroencephalography. 
Neurosurgery 78:169–180, 2016
13. Jayakar P, Gotman J, Harvey AS, Palmini A, Tassi L, Schom-
er D, et al: Diagnostic utility of invasive EEG for epilepsy 
surgery: Indications, modalities, and techniques. Epilepsia 
57:1735–1747, 2016
14. Lefranc M, Capel C, Pruvot AS, Fichten A, Desenclos C, 
Toussaint P, et al: The impact of the reference imaging mo-
dality, registration method and intraoperative flat-panel com-
puted tomography on the accuracy of the ROSA® stereotactic 
robot. Stereotact Funct Neurosurg 92:242–250, 2014
15. Li QH, Zamorano L, Pandya A, Perez R, Gong J, Diaz F: The 
application accuracy of the NeuroMate robot--A quantitative 
comparison with frameless and frame-based surgical local-
ization systems. Comput Aided Surg 7:90–98, 2002
16. Lo Russo G, Tassi L, Cossu M, Cardinale F, Mai R, Castana 
L, et al: Focal cortical resection in malformations of cortical 
development. Epileptic Disord 5 (Suppl 2):S115–S123, 2003
17. McGonigal A, Bartolomei F, Régis J, Guye M, Gavaret M, 
Trébuchon-Da Fonseca A, et al: Stereoelectroencephalog-
raphy in presurgical assessment of MRI-negative epilepsy. 
Brain 130:3169–3183, 2007
18. Minchev G, Kronreif G, Martínez-Moreno M, Dorfer C, 
Micko A, Mert A, et al: A novel miniature robotic guid-
ance device for stereotactic neurosurgical interventions: 
preliminary experience with the iSYS1 robot. J Neurosurg 
126:985–996, 2017
19. Moshé SL, Perucca E, Ryvlin P, Tomson T: Epilepsy: new 
advances. Lancet 385:884–898, 2015
20. Mullin JP, Shriver M, Alomar S, Najm I, Bulacio J, Chauvel 
P, et al: Is SEEG safe? A systematic review and meta-analysis 
of stereo-electroencephalography-related complications. Epi-
lepsia 57:386–401, 2016
21. Munari C, Bancaud J: The role of stereo-electroencephalog-
raphy (SEEG) in the evaluation of partial epileptic seizures, 
in Porter RJ, Morselli PL (eds): The Epilepsies. Bodmin, 
UK: Butterworth & Co., 1985, pp 267–306
22. Munari C, Lo Russo G, Minotti L, Cardinale F, Tassi L, Ka-
hane P, et al: Presurgical strategies and epilepsy surgery in 
children: comparison of literature and personal experiences. 
Childs Nerv Syst 15:149–157, 1999
23. Roessler K, Sommer B, Merkel A, Rampp S, Gollwitzer 
S, Hamer HM, et al: A frameless stereotactic implantation 
technique for depth electrodes in refractory epilepsy utilizing 
intraoperative MR imaging. World Neurosurg 94:206–210, 
2016
24. Schuele SU: Stereoelectroencephalography. J Clin Neuro-
physiol 33:477, 2016
25. Serletis D, Bulacio J, Bingaman W, Najm I, González-
Martínez J: The stereotactic approach for mapping epileptic 
networks: a prospective study of 200 patients. J Neurosurg 
121:1239–1246, 2014
26. Varma TRK, Eldridge P: Use of the NeuroMate stereotactic 
robot in a frameless mode for functional neurosurgery. Int J 
Med Robot 2:107–113, 2006
27. von Langsdorff D, Paquis P, Fontaine D: In vivo measure-
ment of the frame-based application accuracy of the neuro-
mate neurosurgical robot. J Neurosurg 122:191–194, 2015
28. Wiebe S, Blume WT, Girvin JP, Eliasziw M: A randomized, 
controlled trial of surgery for temporal-lobe epilepsy. N Engl 
J Med 345:311–318, 2001
Disclosures
Francesco Cardinale reports a consultant relationship (paid) with 
Renishaw Mayfield, the manufacturer of the Neuromate robotic 
system. He also reports that he has previously served as a consul-
tant (advisory board member) for Medtronic. 
Author Contributions
Conception and design: Cardinale, De Momi, Castana. Acquisi-
tion of data: Rizzi, Cardinale. Analysis and interpretation of 
data: Cardinale. Drafting the article: Rizzi, Cardinale. Critically 
revising the article: Rizzi, Cardinale, Castana. Reviewed submit-
ted version of manuscript: Rizzi, Cardinale, d’Orio, Casaceli, 
Arnulfo, Narizzano, Scorza, Redaelli, Sberna, Moscato, Castana. 
Approved the final version of the manuscript on behalf of all 
authors: Rizzi. Statistical analysis: Cardinale, Nichelatti, Sberna, 
Moscato. Administrative/technical/material support: d’Orio, Casa-
celi, Arnulfo, Narizzano, Scorza, De Momi, Nichelatti, Redaelli. 
Study supervision: Cardinale, d’Orio, Casaceli, Arnulfo, Nariz-
zano, Scorza, De Momi, Redaelli, Sberna, Moscato, Castana.
Correspondence
Michele Rizzi, “Claudio Munari” Center for Epilepsy Surgery, 
Niguarda Hospital, Piazza Ospedale Maggiore 3, Milan 20162, 
Italy. email: michele.rizzi@ospedaleniguarda.it.
